Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-090485
Filing Date
2016-03-28
Accepted
2016-03-28 10:01:14
Documents
63
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v434565_10k.htm 10-K 586239
2 EXHIBIT 23.1 v434565_ex23-1.htm EX-23.1 2767
3 EXHIBIT 31.1 v434565_ex31-1.htm EX-31.1 7586
4 EXHIBIT 31.2 v434565_ex31-2.htm EX-31.2 7964
5 EXHIBIT 32.1 v434565_ex32-1.htm EX-32.1 4237
6 EXHIBIT 32.2 v434565_ex32-2.htm EX-32.2 4369
7 GRAPHIC tpg4.jpg GRAPHIC 43269
  Complete submission text file 0001144204-16-090485.txt   4400751

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT casi-20151231.xml EX-101.INS 933422
9 XBRL TAXONOMY EXTENSION SCHEMA casi-20151231.xsd EX-101.SCH 43715
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casi-20151231_cal.xml EX-101.CAL 34633
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casi-20151231_def.xml EX-101.DEF 255760
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20151231_lab.xml EX-101.LAB 329640
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20151231_pre.xml EX-101.PRE 304184
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

EIN.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20713 | Film No.: 161531053
SIC: 2836 Biological Products, (No Diagnostic Substances)